DE HB332

Establishes the Kratom Consumer Protection Act in Delaware, requiring retailers to disclose factual basis for kratom product claims on labels unless FDA-recognized as a dietary ingredient or approved drug.

Prohibits sale of kratom products that are adulterated, contaminated with dangerous substances or controlled drugs, contain more than 2% 7-Hydroxymitragynine in the alkaloid fraction, or include synthetic alkaloids.

Bans sale, distribution, and marketing of kratom products to individuals under age 21, including restrictions on using cartoons, superheroes, video game references, or images appealing to minors in advertising and packaging.

Imposes civil penalties of up to $1,000 for first violations and $2,000 for subsequent violations, with individuals granted a private right of action to recover damages from retailers who violate the law.

Requires the Division of Alcohol and Tobacco Enforcement to report to the General Assembly by December 31, 2026, on adverse health events observed after use of opioid-like substances including kratom and tianeptine.